Document:

Exhibit
10.83

 

EXECUTIVE
EMPLOYMENT AGREEMENT

 

This
EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) is made as of September 2, 2015 by and between BIORESTORATIVE
THERAPIES, INC., a Delaware corporation (the “Company”), and ROBERT PACCASASSI (the “Executive”).
Certain capitalized terms used in this Agreement are defined in Section 11.

 

RECITALS

 

WHEREAS,
the Company and the Executive desire to enter into an employment agreement which will set forth the terms and conditions upon
which the Executive shall be employed by the Company and upon which the Company shall compensate the Executive.

 

NOW,
THEREFORE, in consideration of the mutual covenants contained herein and other good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:

 

1.
Employment. The Company will employ the
Executive, and the Executive accepts employment with the Company, upon the terms and conditions set forth in this Agreement, for
the period beginning on the Employment Commencement Date set forth on Schedule A to this Agreement and ending as provided in Section
5 (the “Employment Period”).

 

2.
Employment At-Will. Notwithstanding anything
in this Agreement, the Executive and the Company understand and agree that the Executive is an employee at-will, and that the
Executive may resign, or the Company may terminate the Executive’s employment, at any time and for any or for no reason.
Nothing in this Agreement shall be construed to alter the at-will nature of the Executive’s employment.

 

3.
Position and Duties. During the Employment
Period, the Executive will serve in the position set forth on Schedule A to this Agreement and will render such managerial, analytical,
administrative, financial and other executive services to, and shall have such responsibilities on behalf of, the Company and
its Subsidiaries, as are from time to time necessary in connection with the management and affairs of the Company and its Subsidiaries,
in each case subject to the authority of the Board of Directors of the Company (the “Board”) to define and limit such
executive services. The Executive’s responsibilities shall include, without limitation, those set forth on Schedule A attached
hereto. The Executive will devote substantially all of his business time and attention (except for permitted vacation periods
and reasonable periods of illness or other incapacity) to the business and affairs of the Company and its Subsidiaries, provided
that the Executive will be permitted to (i) serve, with the prior written consent of the Board (such consent not to be unreasonably
withheld), as a member of the board of directors or advisory board of charitable organizations, (ii) engage in charitable activities
and community affairs, and (iii) manage his personal investments and affairs, except that the Executive will limit the time devoted
to the activities described in clauses (i), (ii), and (iii) so as not to materially interfere, individually or in the aggregate,
with the performance of his duties and responsibilities hereunder. The Executive will perform his duties and responsibilities
to the best of his abilities in a diligent, trustworthy, businesslike and efficient manner. The Executive will report to the person
set forth on Schedule A or such other person as is determined by the Board. During the Employment Period, the Executive’s
primary work location shall be the Company’s offices at 40 Marcus Drive, Suite One, Melville, New York 11747. The Executive
will have flexibility to telecommute from time to time during the Employment Period provided that the Executive’s telecommuting
schedule is agreed to by the President, Spine/Disc Division of the Company in his sole discretion.

 

    	 	 	 

    	 	 	 

    

 

4.
Salary and Benefits.

 

(a)
Salary. During the Employment Period, the Company will pay the Executive a salary at the rate set forth on Schedule A to
this Agreement (as in effect from time to time, the “Salary”) as compensation for services. The Salary will be payable
in regular installments in accordance with the general payroll practices of the Company and its Subsidiaries and subject to applicable
withholding requirements. The Company agrees to evaluate the Executive’s performance and Salary annually.

 

(b)
Bonus. During the Employment Period, the Executive will be entitled to receive bonuses upon and subject to the terms and
conditions set forth on Schedule A to this Agreement. Any and all cash Bonuses will be payable by December 31 of the year for
which the Bonus is payable, except that (i) to the extent the amount of the Bonus is based upon the Company’s financial
statements for a particular fiscal year, then such portion of the Bonus shall be payable within fifteen (15) days following the
date on which the audit report with respect to such financials is delivered to the Company and (ii) if a Bonus milestone may be
satisfied, and is satisfied, following the end of the year for which the Bonus is payable, the Bonus payable with respect thereto
shall be payable within fifteen (15) days following the date on which the milestone is satisfied.

 

(c)
Benefits. During the Employment Period, the Company will provide the Executive with medical, dental, life, long-term Disability
insurance and other benefits under such plans as the Board may establish or maintain from time to time for similarly situated
employees. The Executive will be entitled to the number of weeks of paid vacation each year set forth on Schedule A attached hereto.
To the extent that the Executive does not use all the vacation time in any year, calculated as of each anniversary of the commencement
of the Employment Period, the unused vacation may not be carried over to the next year.

 

(d)
Reimbursement of Expenses. During the Employment Period, the Company will reimburse the Executive for all reasonable out-of-pocket
expenses incurred by him in the course of performing his duties that are consistent with the Company’s policies in effect
from time to time with respect to travel, entertainment and other business expenses, including a cell phone, subject to the Company’s
requirements with respect to reporting and documentation of such expenses.

 

5.
Termination.

 

(a)
The Employment Period will continue until the earlier of: (i) the Executive’s resignation for any or no reason; (ii) the
death or Disability of the Executive (which determination shall be made in good faith by a qualified physician selected by the
Board or the Company’s insurers, subject to the Executive’s consent which shall not unreasonably be withheld); or
(iii) the giving of notice of termination by the Company (A) for Cause or (B) for any other reason or for no reason (a termination
described in this clause (iii)(B) being a termination by the Company “Without Cause”).

 

    	 	2	 

    	 	 	 

    

 

(b)
If the Company terminates the Employment Period with Cause or Without Cause, or if the Employee resigns his employment, then,
so long as the Executive continues to comply with his continuing obligations hereunder, the Executive will be entitled to receive
all accrued and unpaid Salary and unused vacation time for the then-current annual period (with the right to vacation time being
pro rated for such period through the Termination Date) and all unreimbursed business expenses incurred through the Termination
Date and payable pursuant to Section 4(d), which accrued and unpaid salary, unused vacation and unreimbursed expenses shall be
payable in a lump sum within five (5) days after the Termination Date. The Executive shall also be entitled to any COBRA benefits
to which the Executive is entitled by law (at the Executive’s sole expense).

 

(c)
Upon the Termination Date, the Executive will be deemed to have resigned from each position (if any) that he then holds as an
officer or director of the Company or any Subsidiary, and the Executive will take any action that the Company or any Subsidiary
may reasonably request in order to confirm or evidence such resignation.

 

(d)
Neither the termination or expiration of this Agreement nor the termination of the Executive’s employment with the Company,
whether by the Company or the Executive, whether for Cause or Without Cause, and whether voluntary or involuntary, shall affect
the continuing operation and effect of Section 6 hereof, which shall continue in full force and effect according to its terms.
In addition, neither the termination or expiration of this Agreement nor the termination of the Executive’s employment with
the Company, whether by the Company or the Executive, whether for Cause or Without Cause, and whether voluntary or involuntary,
will result in a termination or waiver of any rights and remedies that the Company may have under this Agreement and applicable
law.

 

(e)
In the event of the termination of this Agreement or the Executive’s employment, whether by the Company or the Executive,
whether for Cause or Without Cause, and whether voluntary or involuntary, except as expressly provided for herein, the Executive
shall not be entitled to any further compensation or benefits.

 

6.
Restrictive Covenants.

 

(a)
The services of the Executive are unique and extraordinary and essential to the business of the Company, especially since the
Executive shall have access to the Company’s customer lists, trade secrets and other privileged and confidential information
essential to the Company’s business. Therefore, the Executive agrees that, as a material inducement to, and a condition
precedent to the Company’s payment obligations hereunder and its other covenants herein, if the term of the Executive’s
employment hereunder shall expire or the Executive’s employment shall at any time terminate for any reason whatsoever, with
Cause or Without Cause, the Executive will not at any time within one (1) year after such expiration or termination (the “Restrictive
Covenant Period”), without the prior written approval of the Company, directly or indirectly, whether individually or as
a principal, officer, stockholder, equity participant, employee, partner, joint venturer, member, manager, director or agent of,
or lender, consultant or independent contractor to, any Person, or in any other capacity, other than on behalf of or for the benefit
of the Company:

 

(i)
anywhere in the United States of America, engage or participate in a business which, as of such expiration or termination date,
is similar to or competitive with, directly or indirectly, that of the Company, and shall not make any investments in any such
similar or competitive entity, except that the Executive may acquire up to one percent (1%) of the outstanding voting stock of
any entity whose securities are listed on a stock exchange or NASDAQ;

 

    	 	3	 

    	 	 	 

    

 

(ii)
cause or seek to persuade any director, officer, employee, customer, account, agent or supplier of, or consultant or independent
contractor to, the Company or others with whom the Company has had a business relationship (collectively, “Business Associates”)
to discontinue or materially modify the status, employment or relationship of such Business Associate with the Company, or to
become employed in any activity similar to or competitive with the activities of the Company;

 

(iii)
cause or seek to persuade any prospective customer, account, supplier or other Business Associate of the Company (which at the
date of cessation of the Executive’s employment with the Company was then actively being solicited by the Company) to determine
not to enter into a business relationship with the Company or to materially modify its contemplated business relationship;

 

(iv)
hire, retain or associate in a business relationship with, directly or indirectly, any director, officer or employee of the Company;
or

 

(v)
solicit or cause or authorize to be solicited, for or on behalf of the Executive or any third party, any business from, or the
entering into a business relationship with, (a) others who are, or were within one (l) year prior to the cessation of the Executive’s
employment with the Company, customers, accounts or other Business Associates of the Company, or (b) any prospective customer,
account or other Business Associate of the Company which at the date of such cessation was then actively being solicited by the
Company.

 

The
foregoing restrictions set forth in this Section 6 shall apply likewise during the Employment Period.

 

(b)
Concurrently herewith, the Executive is executing and delivering to the Company a Confidentiality and Proprietary Rights Agreement.

 

(c)
The Executive agrees that, while he is employed by the Company, he will offer or otherwise make known or available to the Company,
as directed by the CEO or the Board and without additional compensation or consideration, any business prospects, contacts or
other business opportunities that the Executive may discover, find, develop or otherwise have available to the Executive in any
field in which the Company is engaged, and further agrees that any such prospects, contacts or other business opportunities shall
be the property of the Company.

 

    	 	4	 

    	 	 	 

    

 

(d)
For purposes of this Section 6, the term “Company” shall mean and include the Company and any and all Subsidiaries
and Affiliates of the Company in existence from time to time.

 

(e)
In connection with the Executive’s agreement to the restrictions set forth in this Section 6, the Executive acknowledges
the benefits accorded to him pursuant to the provisions of this Agreement, including, without limitation, the agreement on the
part of the Company to employ the Executive during the Employment Period (subject to the terms and conditions hereof). The Executive
also acknowledges and agrees that the covenants set forth in this Section 6 are reasonable and necessary in order to protect and
maintain the proprietary and other legitimate business interests of the Company and that the enforcement thereof would not prevent
the Executive from earning a livelihood.

 

7.
Options. Effective on the Employment Commencement
Date, pursuant and subject to the terms and conditions of the Company’s 2010 Equity Participation Plan and a Stock Option
Agreement, the Executive will be granted the number of options set forth on Schedule A attached hereto under “Options Granted”,
which options will vest as set forth thereon.

 

8.
Deductions and Withholding. The Executive
agrees that the Company shall withhold from any and all payments required to be made to the Executive pursuant to this Agreement
all federal, state, local and/or other taxes that are required to be withheld in accordance with applicable statutes and/or regulations
from time to time in effect.

 

9.
Code Section 409A.

 

(a)
The intent of the parties is that payments and benefits under this Agreement comply with Section 409A of the Internal Revenue
Code of 1986, as amended (together with the regulations and guidance promulgated thereunder, “Code Section 409A”),
and, accordingly, to the maximum extent permitted, this Agreement shall be interpreted to be in compliance therewith. To the extent
that any provision hereof is modified in order to comply with Code Section 409A, such modification shall be made in good faith
and shall, to the maximum extent reasonably possible, maintain the original intent and economic benefit to the parties hereto
of the applicable provision without violating the provisions of Code Section 409A. In no event whatsoever shall the Company be
liable for any additional tax, interest or penalty that may be imposed on the Executive by Code Section 409A.

 

(b)
A termination of employment shall not be deemed to have occurred for purposes of any provision of this Agreement providing for
the payment of any amounts or benefits constituting deferred compensation under Code Section 409A upon or following a termination
of employment unless such termination of employment is also a “separation from service” within the meaning of Code
Section 409A and, for purposes of any such provision of this Agreement, references to a termination of employment or like terms
shall mean “separation from service.” If the Executive is deemed on the date of termination to be a “specified
employee” within the meaning of that term under Code Section 409A(a)(2)(B), then with regard to any payment or the provision
of any benefit that is considered deferred compensation under Code Section 409A payable on account of a “separation from
service,” such payment or benefit shall be made or provided at the date which is the earlier of (i) the expiration of the
six (6) month period measured from the date of such “separation from service” of the Executive, and (ii) the date
of the Executive’s death (the “Delay Period”). Upon the expiration of the Delay Period, all payments and benefits
delayed pursuant to this Section 9(b) (whether they would have otherwise been payable in a single sum or in installments in the
absence of such delay) shall be paid or reimbursed to the Executive in a lump sum, and any remaining payments and benefits due
under this Agreement shall be paid or provided in accordance with the normal payment dates specified herein.

 

    	 	5	 

    	 	 	 

    

 

(c)
All expenses or other reimbursements under this Agreement shall be made on or prior to the last day of the taxable year following
the taxable year in which such expenses were incurred by the Executive (provided that if any such reimbursements constitute taxable
income to the Executive, such reimbursements shall be paid no later than March 15th of the calendar year following the calendar
year in which the expenses to be reimbursed were incurred), and no such reimbursement or expenses eligible for reimbursement in
any taxable year shall in any way affect the expenses eligible for reimbursement in any other taxable year.

 

(d)
For purposes of Code Section 409A, the Executive’s right to receive any installment payments pursuant to this Agreement
shall be treated as a right to receive a series of separate and distinct payments. Whenever a payment under this Agreement specifies
a payment period with reference to a number of days (e.g., “payment shall be made within sixty (60) days”), the actual
date of payment within the specified period shall be within the sole discretion of the Company.

 

(e)
In no event shall any payment under this Agreement that constitutes “deferred compensation” for purposes of Code Section
409A be offset by any other payment pursuant to this Agreement or otherwise.

 

10.
Representations and Warranties. The Executive
represents and warrants to the Company and its Subsidiaries that: (a) the Executive is not a party to or bound by any employment,
noncompete, nonsolicitation, or similar agreement with any other Person; (b) the Executive is not a party to or bound by any nondisclosure,
confidentiality or similar agreement with any other Person that would affect the Executive’s ability to perform his responsibilities
on behalf of the Company; and (c) this Agreement constitutes a valid and legally binding obligation of the Executive, enforceable
against him in accordance with its terms. The Company represents that this Agreement constitutes a valid and legally binding obligation
of the Company, enforceable against it in accordance with its terms. All representations and warranties contained herein will
survive the execution and delivery of this Agreement.

 

11.
Certain Definitions. When used in this
Agreement, the following terms will have the following meanings:

 

“Affiliate”
means, with respect to any Person, any other Person that, directly or indirectly through one or more of its intermediaries, controls,
is controlled by or is under common control with such Person.

 

    	 	6	 

    	 	 	 

    

 

“Cause”
means any one or more of the following: (i) in the reasonable judgment of the Board, the Executive acts (including a failure to
act) in a manner that constitutes gross misconduct or gross negligence or that is otherwise materially injurious to the Company
or its Subsidiaries; (ii) the Executive breaches any material term of this Agreement, which breach remains uncured to the reasonable
satisfaction of the Board following ten (10) days’ written notice from the Company of such breach; provided, however, that
the Company shall not be required to give the Executive a cure period on more than one occasion; (iii) in the reasonable judgment
of the Board, the Executive has committed an act of fraud or misappropriation, or other act of dishonesty or illegal business
practices relating to the Company or any of its Subsidiaries, customers or suppliers; (iv) the Executive’s commission of
any act which, if the Executive were convicted, would constitute a felony, a crime of moral turpitude or a crime involving the
illegal use of drugs, or the Executive’s entry of a plea of guilty or no contest thereto; (v) the Executive’s willful
failure or refusal to perform specific directives of the Board or the CEO; (vi) any alcohol or other substance abuse on the part
of the Executive; (vii) any excessive absence of the Executive from his employment during normal working hours for reasons other
than vacation or disability; (viii) the Executive’s breach of any other material obligation under this Agreement; or (ix)
any misrepresentation on the Executive’s part herein set forth.

 

“CEO”
means the Chief Executive Officer of the Company.

 

“COBRA”
means the Consolidated Omnibus Budget Reconciliation Act of 1985 as amended from time to time.

 

“Disability”
has the meaning that such term has under the Company’s long-term disability insurance plan.

 

“Person”
means an individual, a partnership, a corporation, an association, a limited liability company, a joint stock company, a trust,
a joint venture, an unincorporated organization or any other entity (including any governmental entity or any department, agency
or political subdivision thereof).

 

“Subsidiaries”
means, with respect to any Person, any corporation, limited liability company, partnership, association or other business entity
of which (i) if a corporation, a majority of the total voting power of shares of stock entitled (without regard to the occurrence
of any contingency) to vote in the election of directors thereof is at the time owned or controlled, directly or indirectly, by
such Person or one (1) or more of the other Subsidiaries of such Person or a combination thereof, or (ii) if a limited liability
company, partnership, association or other business entity, a majority of the partnership or other similar ownership interests
thereof is at the time owned or controlled, directly or indirectly, by any Person or one (1) or more Subsidiaries of such Person
or entity or a combination thereof. For purposes hereof, a Person or Persons will be deemed to have a majority ownership interest
in a limited liability company, partnership, association or other business entity if such Person or Persons will be allocated
a majority of limited liability company, partnership, association or other business entity gains or losses or will be or control
any managing director, managing member, or general partner of such limited liability company, partnership, association or other
business entity. Unless stated to the contrary, as used in this Agreement the term Subsidiary means a Subsidiary of the Company.

 

“Termination
Date” means the date on which the Employment Period ends pursuant to Section 5(a).

 

    	 	7	 

    	 	 	 

    

 

12.
Cooperation in Legal Matters. The Executive
will cooperate with the Company and its Subsidiaries during the term of the Executive’s employment and thereafter with respect
to any pending or threatened claim, action, suit, or proceeding, whether civil, criminal, administrative, or investigative (the
“Claims”), by being reasonably available to testify on behalf of the Company or any Subsidiaries, and to assist the
Company and its Subsidiaries by providing information, meeting and consulting with the Company and its Subsidiaries or their representatives
or counsel, as reasonably requested. The Executive agrees not to disclose to or discuss with anyone who is not assisting the Company
or any Subsidiary with the Claims, other than the Executive’s personal attorney, the fact of or the subject matter of the
Claims, except as required by law. The Executive further agrees to maintain the confidences and privileges of the Company and
its Subsidiaries, and acknowledges that any such confidences and privileges belong solely to the Company and its Subsidiaries
and can only be waived by the Company or any Subsidiary, not the Executive. In the event that the Executive is subpoenaed to testify,
or otherwise requested to provide information in any matter relating to the Company or any Subsidiary, the Executive agrees to
promptly notify the Company after receipt of such subpoena, summons or request for information, to reasonably cooperate with the
Company or any Subsidiary with respect to such subpoena, summons or request for information, and to not voluntarily provide any
testimony or information unless required by law or permitted by the Company.

 

13.
Background Check. The Executive agrees
that the Company may undertake a background check with respect to the Executive in connection with the subject matter of this
Agreement in such manner as the Company determines to be appropriate.

 

14.
Miscellaneous.

 

(a)
Notices. All notices, demands or other communications to be given or delivered by reason of the provisions of this Agreement
will be in writing and will be deemed to have been given (i) on the date of personal delivery to the recipient or an officer of
the recipient, (ii) when sent by telecopy or facsimile machine to the number shown below on the date of such confirmed facsimile
or telecopy transmission (provided that a confirming copy is sent via overnight mail), or (iii) when properly deposited for delivery
by a nationally recognized commercial overnight delivery service, prepaid, or by deposit in the United States mail, certified
or registered mail, postage prepaid, return receipt requested. Such notices, demands and other communications will be sent to
each party at the address indicated for such party below:

 

if
to the Executive, to:

 

Robert
Paccasassi

27
Ridge Road

Southampton,
New York 11968

 

    	 	8	 

    	 	 	 

    

 

if
to the Company, to:

 

40
Marcus Drive, Suite One

Melville,
New York 11747

Facsimile:
(631) 760-8414

Attention:
Chief Executive Officer

 

with
a copy, which will not constitute notice to the Company, to:

 

Certilman
Balin Adler & Hyman, LLP

90
Merrick Avenue

East
Meadow, New York 11554

Facsimile:
(516) 296-7111

Attention:
Fred Skolnik, Esq.

 

or
to such other address or to the attention of such other person as the recipient party has specified by prior written notice to
the sending party.

 

(b)
Consent to Amendments. No modification, amendment or waiver of any provision of this Agreement will be effective against
any party hereto unless such modification, amendment or waiver is approved in writing by such party. No other course of dealing
among the Company, the Subsidiaries, and the Executive or any delay in exercising any rights hereunder will operate as a waiver
by any of the parties hereto of any rights hereunder.

 

(c)
Assignability and Binding Effect. This Agreement will be binding upon and inure to the benefit of the Executive and his
heirs, legal representatives, executors, administrators or successors, and will be binding upon and inure to the benefit of the
Company and its successors and assigns. The Executive may not assign, transfer, pledge, encumber, hypothecate or otherwise dispose
of this Agreement, or any of his rights or obligations hereunder, and any such attempted assignment or disposition shall be null
and void and without effect.

 

(d)
Severability. Whenever possible, each provision of this Agreement will be interpreted in such manner as to be effective
and valid under applicable law, but if any provision of this Agreement is held to be prohibited by or invalid under applicable
law, such provision will be ineffective only to the extent of such prohibition or invalidity, without invalidating the remainder
of this Agreement.

 

(e)
Headings and Sections. The headings in this Agreement are inserted for convenience only and are in no way intended to describe,
interpret, define, or limit the scope, extent or intent of this Agreement or any provision of this Agreement. Unless the context
requires otherwise, all references in this Agreement to Sections, Exhibits or Schedules will be deemed to mean and refer to Sections,
Exhibits or Schedules of or to this Agreement.

 

(f)
Governing Law. All issues and questions concerning the application, construction, validity, interpretation and enforcement
of this Agreement and any exhibits and schedules to this Agreement shall be governed by, and construed in accordance with, the
laws of the State of New York, without giving effect to any choice of law or conflict of law rules or provisions that would cause
the application of the laws of any jurisdiction other than the State of New York.

 

    	 	9	 

    	 	 	 

    

 

(g)
Waiver of Jury Trial. EACH PARTY TO THIS AGREEMENT HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY LAW, ANY RIGHT TO
TRIAL BY JURY OF ANY CLAIM, DEMAND, ACTION, OR CAUSE OF ACTION (I) ARISING UNDER THIS AGREEMENT OR (II) IN ANY WAY CONNECTED WITH
OR RELATED OR INCIDENTAL TO THE DEALINGS OF THE PARTIES HERETO IN RESPECT OF THIS AGREEMENT, IN EACH CASE WHETHER NOW EXISTING
OR HEREAFTER ARISING, AND WHETHER IN CONTRACT, TORT, EQUITY, OR OTHERWISE. EACH PARTY TO THIS AGREEMENT HEREBY AGREES AND CONSENTS
THAT ANY SUCH CLAIM, DEMAND, ACTION, OR CAUSE OF ACTION WILL BE DECIDED BY COURT TRIAL WITHOUT A JURY AND THAT THE PARTIES TO
THIS AGREEMENT MAY FILE AN ORIGINAL COUNTERPART OR A COPY OF THIS AGREEMENT WITH ANY COURT AS WRITTEN EVIDENCE OF THE CONSENT
OF THE PARTIES HERETO TO THE WAIVER OF THEIR RIGHT TO TRIAL BY JURY.

 

(h)
Submission to Jurisdiction. ANY AND ALL SUITS, LEGAL ACTIONS OR PROCEEDINGS ARISING OUT OF THIS AGREEMENT WILL BE BROUGHT
IN THE COURTS OF THE STATE OF NEW YORK OR THE UNITED STATES DISTRICT COURT IN THE EASTERN DISTRICT OF NEW YORK, AND EACH PARTY
HEREBY SUBMITS TO AND ACCEPTS THE EXCLUSIVE JURISDICTION OF SUCH COURTS FOR THE PURPOSE OF SUCH SUITS, LEGAL ACTIONS OR PROCEEDINGS.
TO THE FULLEST EXTENT PERMITTED BY LAW, EACH PARTY HERETO HEREBY IRREVOCABLY WAIVES ANY OBJECTION WHICH IT MAY NOW OR HEREAFTER
HAVE TO THE LAYING OF VENUE OR ANY SUCH SUIT, LEGAL ACTION OR PROCEEDING IN ANY SUCH COURT AND HEREBY FURTHER WAIVES ANY CLAIM
THAT ANY SUIT, LEGAL ACTION OR PROCEEDING BROUGHT IN ANY SUCH COURT HAS BEEN BROUGHT IN AN INCONVENIENT FORUM.

 

(i)
Service of Process. WITH RESPECT TO ANY AND ALL SUITS, LEGAL ACTIONS OR PROCEEDINGS ARISING OUT OF THIS AGREEMENT, EACH
PARTY WAIVES PERSONAL SERVICE OF ANY SUMMONS, COMPLAINT OR OTHER PROCESS AND AGREES THAT SERVICE THEREOF MAY BE MADE BY ANY MEANS
SPECIFIED FOR NOTICE PURSUANT TO SECTION 14(a).

 

(j)
Confidentiality. The parties agree that this Agreement is confidential and each party agrees not to disclose any information
regarding the terms of this Agreement to any Person, except that the Company may disclose information regarding the terms of this
Agreement to its Affiliates and any lenders or as required by law or regulation or the rules of any stock exchange or market on
which the Company’s securities are listed or traded, and the Executive may disclose information regarding the terms of this
Agreement to his immediate family. Each party may also disclose this information to its tax, legal or other counsel. Each party
shall instruct each of the foregoing not to disclose the same to anyone.

 

(k)
No Strict Construction. The parties hereto have participated jointly in the negotiation and drafting of this Agreement.
In the event an ambiguity or question of intent or interpretation arises, this Agreement will be construed as if drafted jointly
by the parties hereto, and no presumption or burden of proof will arise favoring or disfavoring any party by virtue of the authorship
of any of the provisions of this Agreement.

 

    	 	10	 

    	 	 	 

    

 

(l)
Entire Agreement. Except as otherwise expressly set forth in this Agreement, this Agreement and the other agreements referred
to in this Agreement embody the complete agreement and understanding among the parties to this Agreement with respect to the subject
matter of this Agreement, and supersede and preempt any prior understandings, agreements, or representations by or among the parties
or their predecessors, written or oral, that may have related to the subject matter of this Agreement in any way. This Agreement
will be deemed effective on the date hereof upon the execution hereof.

 

(m)
Time. Whenever the last day for the exercise of any privilege or the discharge or any duty hereunder falls upon a day that
is not a business day, the party having such privilege or duty may exercise such privilege or discharge such duty on the next
succeeding day that is a business day.

 

(n)
Certain Terms. The use of the word “including” herein means “including without limitation.” Any
definitions used herein defined in the plural will be deemed to include the singular as the context may require and any definitions
used herein defined in the singular will be deemed to include the plural as the context may require. References to “Dollars”
or “$” are references to the lawful currency of the United States of America.

 

[Remainder
of page intentionally left blank. Signature page follows.]

 

    	 	11	 

    	 	 	 

    

 

IN
WITNESS WHEREOF, the parties hereto have executed this Executive Employment Agreement as of the date first written above.

 

	 	BIORESTORATIVE
    THERAPIES, INC.
	 	 	 
	 	By:	 
	 	Name:	Edward
    L Field
	 	Title:	President,
    Spine/Disc Division
	 	 	 
	 	 
	 	Robert
    Paccasassi

 

    	 	 	 

    	 	 	 

    

 

SCHEDULE
A

 

	Position:	Director,
    Quality and Compliance
	 	 
	Employment
    Commencement Date:	September
    14, 2015
	 	 
	Per
    Annum Salary:	$175,000
    
	 	 
	Bonus:	Up
    to 25% (the “Bonus Percentage”) of Per Annum Salary based upon the satisfaction of certain performance goals.
    
	 	 
	 	The
    Bonus payable for the period from the Employment Commencement Date through December 31, 2015 (the “2015 Bonus Period”)
    (the “2015 Bonus”) will be due in the event that certain mutually agreed upon milestones are satisfied. The parties
    agree to establish such milestones within the first two weeks of employment.
	 	 
	The 2015 Bonus amount will be a pro-rated amount based upon the Bonus Percentage being applied to the Executive’s salary earned during the 2015 Bonus Period.
	 	 
	Responsibilities:	Responsible
    for the development and oversight of the Company’s quality and compliance efforts
	 	 
	Report
    to:	President,
    Spine/Disc Division
	 	 
	Vacation:	Four
    (4) weeks
	 	 
	Options
    Granted: 	Number:
    options for the purchase of 5,000 shares of the Company’s common stock (subject to adjustment for stock splits, reverse
    stock splits and the like) will be granted on or about the Employment Commencement Date pursuant and subject to the provisions
    of the Company’s 2010 Equity Participation Plan (the “Plan”). Subject to the terms and conditions of the
    Plan, the options will be exercisable for a period of ten (10) years at an exercise price equal to Fair Market Value (as defined
    in the Plan).
	 	 
		Vesting:
    options for the purchase of 1,667 of such shares shall be exercisable on the first anniversary of the Employment Commencement
    Date; options for the purchase of 1,667 of such shares shall be exercisable on the second anniversary of the Employment Commencement
    Date; and options for the purchase of 1,666 of such shares shall be exercisable on the third anniversary of the Employment
    Commencement Date (in each case, subject to adjustment for stock splits, reverse stock splits and the like).Exhibit
10.84

 

BioRestorative
Therapies, Inc.

40
Marcus Drive, Suite One

Melville,
New York 11747

 

March
24, 2016

 

Robert
Paccasassi

27
Ridge Road

Southampton,
New York 11968

 

Dear
Mr. Paccasassi:

 

Reference
is made to the Executive Employment Agreement, dated as of September 2, 2015, between BioRestorative Therapies, Inc. (the “Company”)
and you (the “Executive”) (the “Employment Agreement”). All capitalized terms used and not defined herein
shall have the meanings ascribed to them in the Employment Agreement.

 

Pursuant
to the Employment Agreement, the Executive is entitled to receive an annual bonus of up to 25% of his Per Annum Salary based upon
the satisfaction of certain performance goals. The parties agree that the performance goals for the year ended December 31, 2016,
and the bonus amount payable with respect thereto, are as set forth on Schedule A attached hereto.

 

In
addition, the parties agree that the performance goals for each calendar year of the Employment Period will be established by
the Board no later than March 31 of such year based upon the level of achievement of the Company’s corporate goals and objectives
for the calendar year with respect to which the Bonus relates and the Executive’s individual performance (in each case,
as determined by the Board).

 

Except
as amended hereby, the Employment Agreement shall continue in full force and effect in accordance with its terms.

 

	 	Very truly yours,
	 	 
	 	BioRestorative Therapies, Inc. 
	 	 
	 	By:
    	                           
	 	 	Mark
    Weinreb, Chief Executive Officer

 

Agreed:

 

	 	 
	Robert
    Paccasassi	 

 

    	 	 	 

    	 

    

 

SCHEDULE
A

 

2016
Bonus Milestones:

 

	 	●	$13,125
    upon completion of the Company’s manufacturing process validation required for submission to the Food and Drug Administration
    (the “FDA”) of an IND application with regard to the commencement of a clinical trial for the Company’s
    BRTX-100 product (the “IND Application”);
	 	 	 
	 	●	$8,750
    in the event the Company files the IND Application with the FDA;
	 	 	 
	 	●	$17,500
    in the event the FDA clears the IND Application;
	 	 	 
	 	●	$4,375
    in the event that BRTX-100 is manufactured in a manner consistent with established quality control and compliance guidelines.

 

It
is understood and agreed that each of the foregoing milestones must be achieved by December 31, 2016 in order for the Executive
to be entitled to receive the Bonus amount. In addition, the Executive must have remained continuously employed with the Company
through the date on which a particular milestone is satisfied in order for the Executive to be entitled to receive the particular
Bonus amount. Any issue as to whether any of the foregoing milestones have been satisfied shall be determined by the Company in
its sole discretion.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00294-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00294-of-00352.parquet"}]]